Literature DB >> 25740846

The embryonic myosin R672C mutation that underlies Freeman-Sheldon syndrome impairs cross-bridge detachment and cycling in adult skeletal muscle.

Alice W Racca1, Anita E Beck2, Margaret J McMillin3, F Steven Korte1, Michael J Bamshad4, Michael Regnier5.   

Abstract

Distal arthrogryposis is the most common known heritable cause of congenital contractures (e.g. clubfoot) and results from mutations in genes that encode proteins of the contractile complex of skeletal muscle cells. Mutations are most frequently found in MYH3 and are predicted to impair the function of embryonic myosin. We measured the contractile properties of individual skeletal muscle cells and the activation and relaxation kinetics of isolated myofibrils from two adult individuals with an R672C substitution in embryonic myosin and distal arthrogryposis syndrome 2A (DA2A) or Freeman-Sheldon syndrome. In R672C-containing muscle cells, we observed reduced specific force, a prolonged time to relaxation and incomplete relaxation (elevated residual force). In R672C-containing muscle myofibrils, the initial, slower phase of relaxation had a longer duration and slower rate, and time to complete relaxation was greatly prolonged. These observations can be collectively explained by a small subpopulation of myosin cross-bridges with greatly reduced detachment kinetics, resulting in a slower and less complete deactivation of thin filaments at the end of contractions. These findings have important implications for selecting and testing directed therapeutic options for persons with DA2A and perhaps congenital contractures in general.
© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25740846      PMCID: PMC4481580          DOI: 10.1093/hmg/ddv084

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  65 in total

1.  Loaded shortening and power output in cardiac myocytes are dependent on myosin heavy chain isoform expression.

Authors:  T J Herron; F S Korte; K S McDonald
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-09       Impact factor: 4.733

Review 2.  The genetics of idiopathic clubfoot.

Authors:  Fred Dietz
Journal:  Clin Orthop Relat Res       Date:  2002-08       Impact factor: 4.176

3.  Myosin binding protein C1: a novel gene for autosomal dominant distal arthrogryposis type 1.

Authors:  Christina A Gurnett; David M Desruisseau; Kevin McCall; Ryan Choi; Zachary I Meyer; Michael Talerico; Sara E Miller; Jeong-Sun Ju; Alan Pestronk; Anne M Connolly; Todd E Druley; Conrad C Weihl; Mathew B Dobbs
Journal:  Hum Mol Genet       Date:  2010-01-02       Impact factor: 6.150

4.  Loss of actomyosin regulation in distal arthrogryposis myopathy due to mutant myosin binding protein-C slow.

Authors:  Maegen A Ackermann; Puja D Patel; Jane Valenti; Yasuharu Takagi; Earl Homsher; James R Sellers; Aikaterini Kontrogianni-Konstantopoulos
Journal:  FASEB J       Date:  2013-05-08       Impact factor: 5.191

5.  Family history, maternal smoking, and clubfoot: an indication of a gene-environment interaction.

Authors:  M A Honein; L J Paulozzi; C A Moore
Journal:  Am J Epidemiol       Date:  2000-10-01       Impact factor: 4.897

6.  Functional diversity among a family of human skeletal muscle myosin motors.

Authors:  Daniel I Resnicow; John C Deacon; Hans M Warrick; James A Spudich; Leslie A Leinwand
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-28       Impact factor: 11.205

7.  Axial and radial forces of cross-bridges depend on lattice spacing.

Authors:  C David Williams; Michael Regnier; Thomas L Daniel
Journal:  PLoS Comput Biol       Date:  2010-12-02       Impact factor: 4.475

8.  Spectrum of mutations that cause distal arthrogryposis types 1 and 2B.

Authors:  Anita E Beck; Margaret J McMillin; Heidi I S Gildersleeve; Phillip R Kezele; Kathryn M Shively; John C Carey; Michael Regnier; Michael J Bamshad
Journal:  Am J Med Genet A       Date:  2013-02-07       Impact factor: 2.802

9.  Calcium binding kinetics of troponin C strongly modulate cooperative activation and tension kinetics in cardiac muscle.

Authors:  Kareen L Kreutziger; Nicoletta Piroddi; Jonathan T McMichael; Chiara Tesi; Corrado Poggesi; Michael Regnier
Journal:  J Mol Cell Cardiol       Date:  2010-10-28       Impact factor: 5.000

10.  Upregulation of cardiomyocyte ribonucleotide reductase increases intracellular 2 deoxy-ATP, contractility, and relaxation.

Authors:  F S Korte; Jin Dai; Kate Buckley; Erik R Feest; Nancy Adamek; Michael A Geeves; Charles E Murry; Michael Regnier
Journal:  J Mol Cell Cardiol       Date:  2011-09-03       Impact factor: 5.000

View more
  26 in total

1.  Finally, We Can Relax: A New Generation of Muscle Models that Incorporate Sarcomere Compliance.

Authors:  Michael Regnier; Yuanhua Cheng
Journal:  Biophys J       Date:  2016-02-02       Impact factor: 4.033

Review 2.  Identification and Recent Approaches for Evaluation and Management of Rehabilitation Concerns for Patients with Freeman-Burian Syndrome: Principles for Global Treatment.

Authors:  Mikaela I Poling; Craig R Dufresne; Rodger J McCormick
Journal:  J Pediatr Genet       Date:  2020-05-07

3.  Preliminary experience with delayed non-operative therapy of multiple hand and wrist contractures in a woman with Freeman-Sheldon syndrome, at ages 24 and 28 years.

Authors:  Rodger J McCormick; Mikaela I Poling; Augusto L Portillo; Robert L Chamberlain
Journal:  BMJ Case Rep       Date:  2015-07-14

4.  Autosomal-Dominant Multiple Pterygium Syndrome Is Caused by Mutations in MYH3.

Authors:  Jessica X Chong; Lindsay C Burrage; Anita E Beck; Colby T Marvin; Margaret J McMillin; Kathryn M Shively; Tanya M Harrell; Kati J Buckingham; Carlos A Bacino; Mahim Jain; Yasemin Alanay; Susan A Berry; John C Carey; Richard A Gibbs; Brendan H Lee; Deborah Krakow; Jay Shendure; Deborah A Nickerson; Michael J Bamshad
Journal:  Am J Hum Genet       Date:  2015-05-07       Impact factor: 11.025

5.  Mutations in DNMT3B Modify Epigenetic Repression of the D4Z4 Repeat and the Penetrance of Facioscapulohumeral Dystrophy.

Authors:  Marlinde L van den Boogaard; Richard J L F Lemmers; Judit Balog; Mariëlle Wohlgemuth; Mari Auranen; Satomi Mitsuhashi; Patrick J van der Vliet; Kirsten R Straasheijm; Rob F P van den Akker; Marjolein Kriek; Marlies E Y Laurense-Bik; Vered Raz; Monique M van Ostaijen-Ten Dam; Kerstin B M Hansson; Elly L van der Kooi; Sari Kiuru-Enari; Bjarne Udd; Maarten J D van Tol; Ichizo Nishino; Rabi Tawil; Stephen J Tapscott; Baziel G M van Engelen; Silvère M van der Maarel
Journal:  Am J Hum Genet       Date:  2016-05-05       Impact factor: 11.025

6.  Defective sarcomere organization and reduced larval locomotion and fish survival in slow muscle heavy chain 1 (smyhc1) mutants.

Authors:  Siping Li; Haishen Wen; Shaojun Du
Journal:  FASEB J       Date:  2019-12-01       Impact factor: 5.191

7.  Freeman-Sheldon syndrome in a 29-year-old woman presenting with rare and previously undescribed features.

Authors:  Robert L Chamberlain; Mikaela I Poling; Augusto L Portillo; Andrés Morales; Rigoberto R T Ramirez; Rodger J McCormick
Journal:  BMJ Case Rep       Date:  2015-10-22

8.  Comparison of skeletal muscle miRNA and mRNA profiles among three pig breeds.

Authors:  Xinhua Hou; Yalan Yang; Shiyun Zhu; Chaoju Hua; Rong Zhou; Yulian Mu; Zhonglin Tang; Kui Li
Journal:  Mol Genet Genomics       Date:  2015-10-12       Impact factor: 3.291

9.  Contractile properties of developing human fetal cardiac muscle.

Authors:  Alice W Racca; Jordan M Klaiman; J Manuel Pioner; Yuanhua Cheng; Anita E Beck; Farid Moussavi-Harami; Michael J Bamshad; Michael Regnier
Journal:  J Physiol       Date:  2015-12-07       Impact factor: 5.182

10.  Effects of Cardiac Troponin I Mutation P83S on Contractile Properties and the Modulation by PKA-Mediated Phosphorylation.

Authors:  Yuanhua Cheng; Steffen Lindert; Lucas Oxenford; An-Yue Tu; Andrew D McCulloch; Michael Regnier
Journal:  J Phys Chem B       Date:  2016-05-18       Impact factor: 2.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.